Sunbelt Securities Inc. boosted its holdings in UnitedHealth Group Inc (NYSE:UNH) by 148.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,912 shares of the healthcare conglomerate’s stock after acquiring an additional 1,738 shares during the period. Sunbelt Securities Inc. owned 301.18% of UnitedHealth Group worth $570,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Blue Chip Partners Inc. purchased a new position in UnitedHealth Group in the 2nd quarter valued at about $110,000. Bruderman Asset Management LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its holdings in shares of UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the period. BDO Wealth Advisors LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth about $121,000. Finally, Acrospire Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after acquiring an additional 400 shares during the period. 86.21% of the stock is currently owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

UNH has been the topic of several recent analyst reports. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein reiterated an “outperform” rating and set a $210.00 price objective on shares of UnitedHealth Group in a report on Tuesday, October 10th. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Jefferies Group increased their price objective on shares of UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a report on Friday, October 13th. Finally, BMO Capital Markets started coverage on shares of UnitedHealth Group in a report on Monday, October 16th. They issued an “outperform” rating and a $250.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $243.22.

In related news, Director William C. Ballard, Jr. sold 10,000 shares of UnitedHealth Group stock in a transaction dated Tuesday, January 23rd. The shares were sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the sale, the director now directly owns 76,637 shares in the company, valued at $18,881,824.06. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Kenneth Irwin Shine sold 198 shares of UnitedHealth Group stock in a transaction dated Friday, January 19th. The shares were sold at an average price of $242.55, for a total transaction of $48,024.90. Following the sale, the director now owns 1,790,567 shares in the company, valued at $434,302,025.85. The disclosure for this sale can be found here. Insiders sold 43,853 shares of company stock worth $9,980,908 over the last quarter. 0.89% of the stock is currently owned by company insiders.

UnitedHealth Group Inc (UNH) opened at $247.41 on Tuesday. UnitedHealth Group Inc has a one year low of $156.49 and a one year high of $250.79. The stock has a market capitalization of $239,210.00, a price-to-earnings ratio of 23.10, a P/E/G ratio of 1.45 and a beta of 0.66. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.70 and a current ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The firm had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. During the same period last year, the business posted $2.11 earnings per share. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. analysts predict that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This news story was first posted by Marea Informative and is the property of of Marea Informative. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.mareainformativa.com/2018/01/30/unitedhealth-group-inc-unh-shares-bought-by-sunbelt-securities-inc-updated-updated-updated.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.